Zacks Research Has Bullish Outlook for CVSA FY2026 Earnings

Adtalem Global Education Inc. (NYSE:CVSA) – Analysts at Zacks Research lifted their FY2026 earnings per share estimates for Adtalem Global Education in a report issued on Thursday, May 21st. Zacks Research analyst Team now forecasts that the company will earn $8.06 per share for the year, up from their previous forecast of $7.88. Zacks Research currently has a “Hold” rating on the stock. The consensus estimate for Adtalem Global Education’s current full-year earnings is $8.04 per share. Zacks Research also issued estimates for Adtalem Global Education’s Q4 2026 earnings at $1.90 EPS, Q1 2027 earnings at $2.00 EPS, Q2 2027 earnings at $2.51 EPS, Q3 2027 earnings at $2.13 EPS, Q4 2027 earnings at $2.29 EPS, FY2027 earnings at $8.94 EPS, Q1 2028 earnings at $2.33 EPS, Q2 2028 earnings at $2.68 EPS, Q3 2028 earnings at $2.53 EPS and FY2028 earnings at $10.16 EPS.

Adtalem Global Education (NYSE:CVSA) last released its quarterly earnings data on Thursday, May 7th. The company reported $1.98 EPS for the quarter, beating analysts’ consensus estimates of $1.73 by $0.25. The business had revenue of $487.03 million during the quarter. Adtalem Global Education had a return on equity of 20.19% and a net margin of 12.26%.The company’s revenue for the quarter was up 4.5% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.92 EPS. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS.

A number of other research firms also recently commented on CVSA. Truist Financial upped their price objective on Adtalem Global Education from $130.00 to $140.00 and gave the company a “buy” rating in a report on Monday, May 11th. Barrington Research reissued an “outperform” rating and issued a $170.00 target price on shares of Adtalem Global Education in a research note on Friday, April 17th. Weiss Ratings began coverage on Adtalem Global Education in a research note on Wednesday, February 25th. They issued a “hold (c+)” rating for the company. Finally, Wall Street Zen cut Adtalem Global Education from a “buy” rating to a “hold” rating in a research note on Saturday, May 9th. Two analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $155.00.

Adtalem Global Education Trading Down 0.2%

NYSE CVSA opened at $124.93 on Monday. The firm has a 50-day moving average of $116.34. The company has a market capitalization of $4.25 billion, a P/E ratio of 19.46, a PEG ratio of 1.04 and a beta of 0.63. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.36. Adtalem Global Education has a 12 month low of $86.97 and a 12 month high of $156.26.

Insider Activity at Adtalem Global Education

In other news, Director Michael W. Malafronte acquired 15,305 shares of Adtalem Global Education stock in a transaction dated Tuesday, March 10th. The stock was bought at an average cost of $100.86 per share, with a total value of $1,543,662.30. Following the completion of the transaction, the director directly owned 16,505 shares of the company’s stock, valued at approximately $1,664,694.30. This represents a 1,275.42% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Karen Sue Cox sold 2,000 shares of the company’s stock in a transaction dated Friday, May 8th. The stock was sold at an average price of $124.50, for a total value of $249,000.00. Following the transaction, the insider directly owned 31,596 shares of the company’s stock, valued at $3,933,702. This represents a 5.95% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders acquired 37,236 shares of company stock valued at $3,752,866 and sold 37,489 shares valued at $4,815,956. 2.50% of the stock is currently owned by corporate insiders.

Key Adtalem Global Education News

Here are the key news stories impacting Adtalem Global Education this week:

• Positive Sentiment: Zacks Research lifted its FY2026 earnings estimate for Adtalem Global Education to $8.06 per share from $7.88, signaling improved expectations for the current fiscal year.
• Neutral Sentiment: Zacks maintained a Hold rating on Adtalem Global Education, implying the stock is viewed as fairly valued rather than a strong buy or sell.
• Negative Sentiment: The firm lowered estimates for several upcoming quarters, including Q4 2026, Q1 2027, Q2 2027, Q3 2027, Q4 2027, and FY2027, which could temper enthusiasm for short-term earnings growth.
• Negative Sentiment: Zacks also cut longer-term FY2028 earnings expectations to $10.16 per share from $10.60, indicating slightly less optimistic growth assumptions further out.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.